MedPage Today on MSN
CAR-T Immune Toxicity Linked to Non-Relapse Mortality Risk in Myeloma
Chimeric antigen receptor (CAR) T-cell therapy-associated immune-related adverse events (CirAEs) were associated with a high ...
Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...
A panelist discusses how CD4 counts serve as measures of immune system status that typically increase by about 200 in the first year of antiretroviral therapy. Although there can be laboratory ...
Researchers have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a pivotal role in anti-tumor immunity. The pre-clinical findings highlight the potential to ...
Researchers at Emory University's Winship Cancer Institute discovered a new form of immune cell known as the stem-like CD4 T cell, which plays an important role in anti-tumor immunity. The ...
Winship Cancer Institute of Emory University researcher Haydn T. Kissick, PhD, and assistant professor, Department of Urology at Emory University School of Medicine. Atlanta, GA — Oct. 23, 2024 — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback